0001140361-16-063350.txt : 20160504
0001140361-16-063350.hdr.sgml : 20160504
20160504161651
ACCESSION NUMBER: 0001140361-16-063350
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160429
FILED AS OF DATE: 20160504
DATE AS OF CHANGE: 20160504
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ajer Jeffrey Robert
CENTRAL INDEX KEY: 0001557533
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 161619546
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2016-04-29
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001557533
Ajer Jeffrey Robert
C/O BIOMARIN PHARMACEUTICAL INC.,
105 DIGITAL DRIVE
NOVATO
CA
94949
0
1
0
0
EVP, Chief Commercial Officer
Common Stock
2016-04-29
2016-04-29
4
A
0
415
51.264
A
63487
D
Common Stock
2016-05-03
2016-05-03
4
S
0
415
86.0259
D
63072
D
The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 1, 2015 to April 30, 2016.
Transaction made pursuant to a Rule 10b5-1 trading plan executed on May 11, 2015.
The price in column 4 is a weighted average price. The price actually received ranged from $85.32 to $86.85. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range
/s/ Laura Randall Woodhead, Attorney-in-Fact
2016-05-04